Sekitani Kazuki

External Director at GNI Group

After graduating from Tokyo University with a degree in Economics, Kazuki Sekitani worked for both domestic and multinational companies, leading various business areas such as Corporate Planning, Organization and Human Resource Strategy, M&A/PMI, Operation, and Change Management in the healthcare, financial, and IT industries. In the healthcare industry, he held executive roles at Kaken Pharmaceutical Co. Ltd and EPS Holdings Inc. (current). At Kaken, he served as Managing Director and Board member, leading R&D of new drugs and licensing in and out. At EPS, a leading company in the Contract Research Organization industry, he held various senior executive positions such as Corporate Planning and Administration. He currently holds the Vice Chairman position in charge of Organization and Human Resources. Previously, he worked for GE Capital and Sun Microsystems as Executive Director, and served as President (Country Leader) at Met Life Direct in Japan.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


GNI Group

GNI Group Ltd. is a Japan-based company engaged in new drug production activities utilizing biotechnologies. The Company is engaged in the development of therapeutic agents for diseases that have many sufferers in Asian countries such as Japan and China, as well as clinical trial and bio-verification test businesses. It is engaged in research and development of therapeutic agents, including F647 for radiation pneumonia (RP) and idiopathic pulmonary fibrosis (IPF), F351 for liver fibrosis (cirrhosis) and F573 for acute hepatic insufficiency and acute chronic liver failure (ACLF).


Industries

Headquarters

Chuo-Ku, Japan

Employees

201-500

Links